NewcelX Employees

As of December 31, 2024, NewcelX had 15 total employees, including 11 full-time and 4 part-time employees. The number of employees increased by 3 or 25.00% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

25.00%

Revenue / Employee

n/a

Profits / Employee

-$1,232,679

Market Cap

15.27M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	15	3	25.00%
Dec 31, 2023	12	-19	-61.29%
Dec 31, 2022	31	-1	-3.13%
Dec 31, 2020	32	-	-

Related Stocks

Company Name	Employees
Passage Bio	24
Citius Pharmaceuticals	23
IN8bio	17
SeaStar Medical Holding	17
Theriva Biologics	16
Lipocine	14
Cocrystal Pharma	10
Genenta Science	9

Employee Rankings

NCEL News

8 days ago - NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference - GlobeNewsWire
27 days ago - NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing - GlobeNewsWire
7 weeks ago - NewcelX Announces Strategic Collaboration with Eledon Pharmaceuticals to Advance NCEL-101 Program for Type 1 Diabetes - PRNewsWire
2 months ago - NewcelX Reports Peer-Reviewed Publication Supporting Mazindol IR/SR and Advances CVR Monetization Strategy - PRNewsWire
3 months ago - NewcelX Announces Updated Corporate Presentation Ahead of Key Spring 2026 Investor and Partnering Conferences - PRNewsWire
3 months ago - NewcelX Announce Positive Results from International Collaborative Study Exploring Advanced Biomaterial Approaches for Stem Cell-Derived Islet Delivery in Type 1 Diabetes Without Immune Suppression - PRNewsWire
4 months ago - NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board - PRNewsWire
4 months ago - NewcelX Expands Intellectual Property Footprint with Publication of DOXA Patent Application in China - PRNewsWire

More News